Bioweek
Home
Blog
Tenpoint Therapeutics Secures FDA Approval for Yuvezzi: First Dual-Agent Eye Drop Transforms Presbyopia Treatment Landscape
January 31, 2026
The Latest
Quetzal Therapeutics Advances Oral Arsenic Trioxide with FDA Fast Track Designation: Redefining Convenience in Rare Cancer Treatment
January 31, 2026
Micoy Therapeutics Secures FDA Breakthrough Designation for Revolutionary Point-of-Care Folate Receptor Autoantibody Test
January 31, 2026
Life Biosciences Breaks New Ground with First FDA-Approved Human Trial of Cellular Rejuvenation Therapy
January 31, 2026
Biogen’s Litifilimab Achieves FDA Breakthrough Status: A New Hope for Cutaneous Lupus Patients
January 30, 2026
Longeveron Secures Critical FDA Meeting Ahead of Pivotal HLHS Stem Cell Therapy Data
January 30, 2026
Battle for Avadel: Alkermes vs. Lundbeck in High-Stakes Pharma Acquisition Tussle
November 20, 2025
Agios Pharmaceuticals Faces Stock Plunge as Pyrukynd’s Mixed Sickle Cell Trial Results Spark Regulatory Concerns
News
·
November 20, 2025
1
2
Next Page
